Clinical Trial Update: Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a combination of 5-fluorouracil, leucovorin, and irinotecan (CPT-11) in patients with resectable liver metastases from colorectal cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Alberta Health services | Conditions: Colorectal Adenocarcinoma, Liver Metastases | Phase 2 | Status: COMPLETED